Small Animal Imaging (In-Vivo) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global forecast to 2021
The global small animal imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is projected to be valued at USD 910.4 million by 2021. Market growth in the global small animal imaging market is mainly driven by factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches. In addition, emerging markets (such as China and India) are offering new growth opportunities for small animal imaging market players.
Although the mature markets (North America and Europe) held large share of small animal imaging market in 2015; Asia-Pacific region is poised to be the fastest growing region during the next five years. The large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems. However, continued outsourcing of in-house preclinical studies to emerging countries by U.S.-based pharmaceutical and biotechnology companies and reduced R&D expenditure by the Canadian government to support research studies are negatively affecting the growth of the small animal imaging market in this region.
The small animal imaging market is fairly competitive, with a large number of global and local manufacturers that offer innovative small animal imaging solutions. As of 2015, PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), and FUJIFILM Holding Corporation (Japan) were the top three players in the small animal imaging market. These companies together accounted for a share of 63.2% of the global small animal imaging market in 2015. New product launches and product enhancements; geographic expansions; and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the small animal imaging market.
Report Objective:
This report studies small animal imaging market based on modality and reagents; utilized for the assessment of anatomical, physiological, and functional parameters at molecular and cellular levels in live animal models. These imaging systems and reagents are applied to visualize living animals during preclinical research studies in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications.
The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the small animal imaging market report analyzes the micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market.
Detailed Segmentation:
Small Animal Imaging Market, by Modality
Although the mature markets (North America and Europe) held large share of small animal imaging market in 2015; Asia-Pacific region is poised to be the fastest growing region during the next five years. The large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems. However, continued outsourcing of in-house preclinical studies to emerging countries by U.S.-based pharmaceutical and biotechnology companies and reduced R&D expenditure by the Canadian government to support research studies are negatively affecting the growth of the small animal imaging market in this region.
The small animal imaging market is fairly competitive, with a large number of global and local manufacturers that offer innovative small animal imaging solutions. As of 2015, PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), and FUJIFILM Holding Corporation (Japan) were the top three players in the small animal imaging market. These companies together accounted for a share of 63.2% of the global small animal imaging market in 2015. New product launches and product enhancements; geographic expansions; and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the small animal imaging market.
Report Objective:
This report studies small animal imaging market based on modality and reagents; utilized for the assessment of anatomical, physiological, and functional parameters at molecular and cellular levels in live animal models. These imaging systems and reagents are applied to visualize living animals during preclinical research studies in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications.
The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the small animal imaging market report analyzes the micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market.
Detailed Segmentation:
Small Animal Imaging Market, by Modality
- Optical Imaging Systems
- Bioluminescence/Fluorescence Imaging Systems
- Standalone Fluorescence Imaging Systems
- Optical + X-Ray/Optical + CT
- Nuclear Imaging Systems
- PET Systems
- SPECT Systems
- Trimodality (SPECT/PET/CT) Systems
- MRI Systems
- Ultrasound Systems
- CT Systems
- Photo-acoustic Imaging Systems
- Magnetic Particle Imaging (MPI) Systems
- Optical Imaging Reagents
- Bioluminescent Imaging Reagents
- Fluorescent Imaging Reagents
- Nuclear Imaging Reagents
- PET Tracers
- SPECT Probes
- MRI Contrast Agents
- Gadolinium-based Preclinical MRI Contrast Agents
- Iron-based Preclinical MRI Contrast Agents
- Manganese-based Preclinical MRI Contrast Agents
- Ultrasound Contrast Agents
- CT Contrast Agents
- Iodine-based Preclinical CT Contrast Agents
- Barium-based Preclinical CT Contrast Agents
- Gold Nanoparticles
- Gastrografin-based Preclinical CT Contrast Agents
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Preclinical Imaging System Manufacturers, Suppliers, and Imaging Software Providers
- Pharmaceutical and Biotechnology Companies
- Small Animal Imaging Reagent Manufacturers and Suppliers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.1.1 Small animal imaging market segmentation
1.3.1.2 Small animal imaging systems market segmentation
1.3.1.3 Small animal imaging reagents market segmentation
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1.1 Bottom-up approach
2.2.1.2 Top-down approach
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL SMALL ANIMAL IMAGING MARKET
4.2 SMALL ANIMAL IMAGING PRODUCTS MARKET SHARE, BY REGION (2016)
4.3 GLOBAL SMALL ANIMAL IMAGING SYSTEMS MARKET, BY MODALITY (2016–2021)
4.4 GLOBAL SMALL ANIMAL IMAGING REAGENTS MARKET, BY TYPE (2016–2021)
4.5 SMALL ANIMAL IMAGING MARKET, BY REGION (2016 VS. 2021)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 KEY MARKET DRIVERS
5.2.1.1 Technological advancements in the field of molecular imaging
5.2.1.2 Increasing market demand for noninvasive small-animal imaging techniques
5.2.1.3 Growing number of public-private initiatives and funding to support preclinical researches
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Strict regulations governing preclinical research
5.2.2.2 Significant installation and operational costs associated with preclinical imaging modalities
5.2.3 KEY MARKET OPPORTUNITY
5.2.3.1 Emerging markets to offer new growth opportunities
5.2.4 KEY MARKET CHALLENGE
5.2.4.1 Technological and procedural limitations associated with standalone small animal imaging systems
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 SUPPLY CHAIN ANALYSIS
6.3.1 KEY STAKEHOLDERS
6.3.2 KEY INFLUENCERS
6.4 KEY INDUSTRY TREND
6.4.1 ONGOING DEVELOPMENT OF HYBRID AND MULTI-MODALITY PRECLINICAL IMAGING SYSTEMS
6.5 PORTER’S FIVE FORCES ANALYSIS
6.5.1 THREAT OF NEW ENTRANTS
6.5.2 THREAT OF SUBSTITUTES
6.5.3 BARGAINING POWER OF SUPPLIERS
6.5.4 BARGAINING POWER OF BUYERS
6.5.5 INTENSITY OF COMPETITIVE RIVALRY
7 GLOBAL SMALL ANIMAL IMAGING MARKET, BY MODALITY
7.1 INTRODUCTION
7.2 OPTICAL IMAGING SYSTEMS
7.2.1 BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS
7.2.2 (OPTICAL + X-RAY)/(OPTICAL + CT) IMAGING SYSTEMS
7.2.3 STANDALONE FLUORESCENCE IMAGING SYSTEMS
7.3 NUCLEAR IMAGING SYSTEMS
7.3.1 MICRO-PET SYSTEMS
7.3.1.1 Standalone PET Systems
7.3.1.2 PET/CT Systems
7.3.1.3 PET/MRI Systems
7.3.2 MICRO-SPECT SYSTEMS
7.3.2.1 Standalone SPECT Systems
7.3.2.2 SPECT/CT Systems
7.3.2.3 SPECT/MRI Systems
7.3.3 TRIMODALITY (SPECT/PET/CT) SYSTEMS
7.4 MICRO-MRI SYSTEMS
7.5 MICRO-ULTRASOUND SYSTEMS
7.6 MICRO-CT SYSTEMS
7.7 PHOTOACOUSTIC IMAGING SYSTEMS
7.8 MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS
8 GLOBAL SMALL ANIMAL IMAGING MARKET, BY REAGENT
8.1 INTRODUCTION
8.2 PRECLINICAL OPTICAL IMAGING REAGENTS
8.2.1 BIOLUMINESCENT IMAGING REAGENTS
8.2.1.1 Luciferins
8.2.1.2 Proluciferins
8.2.1.3 Coelenterazine
8.2.1.4 Other Bioluminescent Imaging Reagents
8.2.2 FLUORESCENT IMAGING REAGENTS
8.2.2.1 Green Fluorescent Proteins
8.2.2.2 Red Fluorescent Proteins
8.2.2.3 Infrared Dyes
8.2.2.4 Other fluorescent imaging reagents
8.3 PRECLINICAL NUCLEAR IMAGING REAGENTS
8.3.1 PRECLINICAL PET TRACERS
8.3.1.1 Fluorine-18-based Preclinical PET Tracers
8.3.1.2 Carbon-11-based Preclinical PET Tracers
8.3.1.3 Copper-64-based Preclinical PET Tracers
8.3.1.4 Other PET tracers
8.3.2 PRECLINICAL SPECT PROBES
8.3.2.1 Technetium-99m-based Preclinical SPECT Probes
8.3.2.2 Iodine-131-based Preclinical SPECT Probes
8.3.2.3 Gallium-67-based Preclinical SPECT Probes
8.3.2.4 Thallium-201-based Preclinical SPECT Probes
8.3.2.5 Other SPECT probes
8.4 PRECLINICAL MRI CONTRAST AGENTS
8.4.1 GADOLINIUM-BASED PRECLINICAL CONTRAST AGENTS
8.4.2 IRON-BASED PRECLINICAL CONTRAST AGENTS
8.4.3 MANGANESE-BASED PRECLINICAL CONTRAST AGENTS
8.5 PRECLINICAL ULTRASOUND CONTRAST AGENTS
8.6 PRECLINICAL CT CONTRAST AGENTS
8.6.1 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS
8.6.2 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS
8.6.3 GOLD NANOPARTICLES
8.6.4 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS
9 SMALL ANIMAL IMAGING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.3 EUROPE
9.4 ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
10.3 COMPETITIVE SCENARIO
10.3.1 NEW PRODUCT LAUNCHES
10.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.3.3 GEOGRAPHICAL EXPANSIONS
10.3.4 ACQUISITIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION
11.1.1 GEOGRAPHIC BENCHMARKING
11.2 PERKINELMER, INC.
11.3 BRUKER CORPORATION
11.4 FUJIFILM HOLDINGS CORPORATION
11.5 MEDISO LTD.
11.6 MILABS B.V.
11.7 MR SOLUTIONS LTD.
11.8 ASPECT IMAGING LTD.
11.9 LI-COR BIOSCIENCES, INC.
11.10 TRIFOIL IMAGING, INC.
11.11 MILTENYI BIOTEC GMBH
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.1.1 Small animal imaging market segmentation
1.3.1.2 Small animal imaging systems market segmentation
1.3.1.3 Small animal imaging reagents market segmentation
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1.1 Bottom-up approach
2.2.1.2 Top-down approach
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL SMALL ANIMAL IMAGING MARKET
4.2 SMALL ANIMAL IMAGING PRODUCTS MARKET SHARE, BY REGION (2016)
4.3 GLOBAL SMALL ANIMAL IMAGING SYSTEMS MARKET, BY MODALITY (2016–2021)
4.4 GLOBAL SMALL ANIMAL IMAGING REAGENTS MARKET, BY TYPE (2016–2021)
4.5 SMALL ANIMAL IMAGING MARKET, BY REGION (2016 VS. 2021)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 KEY MARKET DRIVERS
5.2.1.1 Technological advancements in the field of molecular imaging
5.2.1.2 Increasing market demand for noninvasive small-animal imaging techniques
5.2.1.3 Growing number of public-private initiatives and funding to support preclinical researches
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Strict regulations governing preclinical research
5.2.2.2 Significant installation and operational costs associated with preclinical imaging modalities
5.2.3 KEY MARKET OPPORTUNITY
5.2.3.1 Emerging markets to offer new growth opportunities
5.2.4 KEY MARKET CHALLENGE
5.2.4.1 Technological and procedural limitations associated with standalone small animal imaging systems
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 SUPPLY CHAIN ANALYSIS
6.3.1 KEY STAKEHOLDERS
6.3.2 KEY INFLUENCERS
6.4 KEY INDUSTRY TREND
6.4.1 ONGOING DEVELOPMENT OF HYBRID AND MULTI-MODALITY PRECLINICAL IMAGING SYSTEMS
6.5 PORTER’S FIVE FORCES ANALYSIS
6.5.1 THREAT OF NEW ENTRANTS
6.5.2 THREAT OF SUBSTITUTES
6.5.3 BARGAINING POWER OF SUPPLIERS
6.5.4 BARGAINING POWER OF BUYERS
6.5.5 INTENSITY OF COMPETITIVE RIVALRY
7 GLOBAL SMALL ANIMAL IMAGING MARKET, BY MODALITY
7.1 INTRODUCTION
7.2 OPTICAL IMAGING SYSTEMS
7.2.1 BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS
7.2.2 (OPTICAL + X-RAY)/(OPTICAL + CT) IMAGING SYSTEMS
7.2.3 STANDALONE FLUORESCENCE IMAGING SYSTEMS
7.3 NUCLEAR IMAGING SYSTEMS
7.3.1 MICRO-PET SYSTEMS
7.3.1.1 Standalone PET Systems
7.3.1.2 PET/CT Systems
7.3.1.3 PET/MRI Systems
7.3.2 MICRO-SPECT SYSTEMS
7.3.2.1 Standalone SPECT Systems
7.3.2.2 SPECT/CT Systems
7.3.2.3 SPECT/MRI Systems
7.3.3 TRIMODALITY (SPECT/PET/CT) SYSTEMS
7.4 MICRO-MRI SYSTEMS
7.5 MICRO-ULTRASOUND SYSTEMS
7.6 MICRO-CT SYSTEMS
7.7 PHOTOACOUSTIC IMAGING SYSTEMS
7.8 MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS
8 GLOBAL SMALL ANIMAL IMAGING MARKET, BY REAGENT
8.1 INTRODUCTION
8.2 PRECLINICAL OPTICAL IMAGING REAGENTS
8.2.1 BIOLUMINESCENT IMAGING REAGENTS
8.2.1.1 Luciferins
8.2.1.2 Proluciferins
8.2.1.3 Coelenterazine
8.2.1.4 Other Bioluminescent Imaging Reagents
8.2.2 FLUORESCENT IMAGING REAGENTS
8.2.2.1 Green Fluorescent Proteins
8.2.2.2 Red Fluorescent Proteins
8.2.2.3 Infrared Dyes
8.2.2.4 Other fluorescent imaging reagents
8.3 PRECLINICAL NUCLEAR IMAGING REAGENTS
8.3.1 PRECLINICAL PET TRACERS
8.3.1.1 Fluorine-18-based Preclinical PET Tracers
8.3.1.2 Carbon-11-based Preclinical PET Tracers
8.3.1.3 Copper-64-based Preclinical PET Tracers
8.3.1.4 Other PET tracers
8.3.2 PRECLINICAL SPECT PROBES
8.3.2.1 Technetium-99m-based Preclinical SPECT Probes
8.3.2.2 Iodine-131-based Preclinical SPECT Probes
8.3.2.3 Gallium-67-based Preclinical SPECT Probes
8.3.2.4 Thallium-201-based Preclinical SPECT Probes
8.3.2.5 Other SPECT probes
8.4 PRECLINICAL MRI CONTRAST AGENTS
8.4.1 GADOLINIUM-BASED PRECLINICAL CONTRAST AGENTS
8.4.2 IRON-BASED PRECLINICAL CONTRAST AGENTS
8.4.3 MANGANESE-BASED PRECLINICAL CONTRAST AGENTS
8.5 PRECLINICAL ULTRASOUND CONTRAST AGENTS
8.6 PRECLINICAL CT CONTRAST AGENTS
8.6.1 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS
8.6.2 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS
8.6.3 GOLD NANOPARTICLES
8.6.4 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS
9 SMALL ANIMAL IMAGING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.3 EUROPE
9.4 ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
10.3 COMPETITIVE SCENARIO
10.3.1 NEW PRODUCT LAUNCHES
10.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.3.3 GEOGRAPHICAL EXPANSIONS
10.3.4 ACQUISITIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION
11.1.1 GEOGRAPHIC BENCHMARKING
11.2 PERKINELMER, INC.
11.3 BRUKER CORPORATION
11.4 FUJIFILM HOLDINGS CORPORATION
11.5 MEDISO LTD.
11.6 MILABS B.V.
11.7 MR SOLUTIONS LTD.
11.8 ASPECT IMAGING LTD.
11.9 LI-COR BIOSCIENCES, INC.
11.10 TRIFOIL IMAGING, INC.
11.11 MILTENYI BIOTEC GMBH
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
LIST OF TABLES
Table 1 SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014–2021 (USD MILLION)
Table 2 GLOBAL OPTICAL IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 3 OPTICAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012–2014 (USD MILLION)
Table 5 (OPTICAL + X-RAY)/(OPTICAL + CT) IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012–2014 (USD MILLION)
Table 6 STANDALONE FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012–2014 (USD MILLION)
Table 7 GLOBAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 8 NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 9 GLOBAL MICRO-PET SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 10 MICRO-PET SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 STANDALONE PET SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 PET/CT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 13 PET/MRI SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 GLOBAL MICRO-SPECT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 15 MICRO-SPECT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 STANDALONE SPECT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 SPECT/CT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 SPECT/MRI SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 TRIMODALITY SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 MICRO-MRI SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 MICRO-ULTRASOUND SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 MICRO-CT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 PHOTOACOUSTIC IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 GLOBAL SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 26 GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 27 PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 GLOBAL PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 29 PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 30 PRECLINICAL LUCIFERINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 31 PRECLINICAL PROLUCIFERINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 32 PRECLINICAL COELENTERAZINE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 33 OTHER PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 GLOBAL PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 35 PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 36 PRECLINICAL GREEN FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 37 PRECLINICAL RED FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 38 PRECLINICAL INFRARED DYES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 39 OTHER PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 40 GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 41 PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 42 GLOBAL PRECLINICAL PET TRACERS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 43 PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 44 FLUORINE-18-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 45 CARBON-11-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 46 COPPER-64-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 47 OTHER PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 48 GLOBAL PRECLINICAL SPECT PROBES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 49 PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 50 TECHNETIUM-99M-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 51 IODINE-131-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 52 GALLIUM-67-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 53 THALLIUM-201-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 54 OTHER PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 55 GLOBAL PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 56 PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 57 GADOLINIUM-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 58 IRON-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 59 MANGANESE-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 60 PRECLINICAL ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 61 GLOBAL PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 62 PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 63 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 64 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 65 GOLD NANOPARTICLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 66 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 67 GLOBAL SMALL ANIMAL IMAGING SYSTEMS AND REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 68 NORTH AMERICA: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 69 NORTH AMERICA: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014–2021 (USD MILLION)
Table 70 NORTH AMERICA: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 71 EUROPE: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 72 EUROPE: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014–2021 (USD MILLION)
Table 73 EUROPE: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 74 ASIA-PACIFIC: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 75 ASIA-PACIFIC: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
Table 76 ASIA-PACIFIC: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 ROW: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 78 ROW: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
Table 79 ROW: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 80 TOP NEW PRODUCT LAUNCHES, 2013–2016
Table 81 TOP AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016
Table 82 TOP GEOGRAPHICAL EXPANSIONS, 2013–2016
Table 83 TOP ACQUISITIONS, 2013–2016
Table 1 SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014–2021 (USD MILLION)
Table 2 GLOBAL OPTICAL IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 3 OPTICAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012–2014 (USD MILLION)
Table 5 (OPTICAL + X-RAY)/(OPTICAL + CT) IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012–2014 (USD MILLION)
Table 6 STANDALONE FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012–2014 (USD MILLION)
Table 7 GLOBAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 8 NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 9 GLOBAL MICRO-PET SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 10 MICRO-PET SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 STANDALONE PET SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 PET/CT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 13 PET/MRI SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 GLOBAL MICRO-SPECT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 15 MICRO-SPECT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 STANDALONE SPECT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 SPECT/CT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 SPECT/MRI SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 TRIMODALITY SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 MICRO-MRI SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 MICRO-ULTRASOUND SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 MICRO-CT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 PHOTOACOUSTIC IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 GLOBAL SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 26 GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 27 PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 GLOBAL PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 29 PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 30 PRECLINICAL LUCIFERINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 31 PRECLINICAL PROLUCIFERINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 32 PRECLINICAL COELENTERAZINE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 33 OTHER PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 GLOBAL PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 35 PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 36 PRECLINICAL GREEN FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 37 PRECLINICAL RED FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 38 PRECLINICAL INFRARED DYES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 39 OTHER PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 40 GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 41 PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 42 GLOBAL PRECLINICAL PET TRACERS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 43 PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 44 FLUORINE-18-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 45 CARBON-11-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 46 COPPER-64-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 47 OTHER PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 48 GLOBAL PRECLINICAL SPECT PROBES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 49 PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 50 TECHNETIUM-99M-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 51 IODINE-131-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 52 GALLIUM-67-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 53 THALLIUM-201-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 54 OTHER PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 55 GLOBAL PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 56 PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 57 GADOLINIUM-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 58 IRON-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 59 MANGANESE-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 60 PRECLINICAL ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 61 GLOBAL PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 62 PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 63 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 64 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 65 GOLD NANOPARTICLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 66 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 67 GLOBAL SMALL ANIMAL IMAGING SYSTEMS AND REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 68 NORTH AMERICA: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 69 NORTH AMERICA: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014–2021 (USD MILLION)
Table 70 NORTH AMERICA: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 71 EUROPE: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 72 EUROPE: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014–2021 (USD MILLION)
Table 73 EUROPE: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 74 ASIA-PACIFIC: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 75 ASIA-PACIFIC: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
Table 76 ASIA-PACIFIC: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 ROW: SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 78 ROW: SMALL ANIMAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
Table 79 ROW: SMALL ANIMAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 80 TOP NEW PRODUCT LAUNCHES, 2013–2016
Table 81 TOP AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016
Table 82 TOP GEOGRAPHICAL EXPANSIONS, 2013–2016
Table 83 TOP ACQUISITIONS, 2013–2016
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 SMALL ANIMAL IMAGING SYSTEMS MARKET: BOTTOM-UP APPROACH
Figure 4 SMALL ANIMAL IMAGING SYSTEMS MARKET: TOP-DOWN APPROACH
Figure 5 SMALL ANIMAL IMAGING REAGENTS MARKET: TOP-DOWN APPROACH
Figure 6 SMALL ANIMAL IMAGING MARKET: DATA TRIANGULATION
Figure 7 GLOBAL SMALL ANIMAL IMAGING SYSTEMS MARKET, BY MODALITY, 2016 VS. 2021 (USD MILLION)
Figure 8 GLOBAL SMALL ANIMAL IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 9 GLOBAL SMALL ANIMAL IMAGING MARKET, BY REGION, 2016
Figure 10 TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR IMAGING AND INCREASING DEMAND FOR NONINVASIVE TECHNIQUES—KEY MARKET DRIVERS
Figure 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE SMALL ANIMAL IMAGING MARKET IN 2016
Figure 12 OPTICAL IMAGING, NUCLEAR IMAGING, AND MICRO-MRI SYSTEMS TO DOMINATE THE SMALL ANIMAL IMAGING SYSTEMS MARKET TILL 2021
Figure 13 OPTICAL IMAGING, NUCLEAR IMAGING REAGENTS, AND MRI CONTRAST AGENTS TO DOMINATE THE SMALL ANIMAL IMAGING REAGENTS MARKET TILL 2021
Figure 14 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SMALL ANIMAL IMAGING MARKET IN 2016
Figure 15 TECHNOLOGICAL ADVANCEMENTS & EMERGING APPLICATION SEGMENTS TO DRIVE THE GROWTH OF THE SMALL ANIMAL IMAGING MARKET TILL 2021
Figure 16 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES, 2000–2013
Figure 17 MAJORITY OF PRODUCT VALUE OF SMALL ANIMAL IMAGING SYSTEMS IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
Figure 18 MARKET PLAYERS PREFER BOTH DIRECT & INDIRECT DISTRIBUTION STRATEGIES
Figure 19 PORTER’S FIVE FORCES ANALYSIS: SMALL ANIMAL IMAGING MARKET (2015)
Figure 20 OPTICAL IMAGING SYSTEMS TO DOMINATE SMALL ANIMAL IMAGING SYSTEMS MARKET TILL 2021
Figure 21 OPTICAL IMAGING SYSTEMS MARKET TO BE DOMINATED BY BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS IN 2016
Figure 22 MICRO-PET SYSTEMS TO DOMINATE THE NUCLEAR IMAGING SYSTEMS MARKET TILL 2021
Figure 23 MAGNETIC PARTICLE IMAGING VS. OTHER SMALL ANIMAL IMAGING MODALITIES – ADVANTAGES AND KEY APPLICATION AREAS
Figure 24 OPTICAL IMAGING REAGENTS TO DOMINATE THE SMALL ANIMAL IMAGING REAGENTS MARKET TILL 2021
Figure 25 PRECLINICAL OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 26 PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 27 PRECLINICAL MRI CONTRAST AGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 28 PRECLINICAL CT CONTRAST AGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 29 ASIA-PACIFIC TO BE THE FASTEST-GROWING REGION IN GLOBAL SMALL ANIMAL IMAGING MARKET DURING THE FORECAST PERIOD
Figure 30 NORTH AMERICA: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 31 EUROPE: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 32 ASIA-PACIFIC: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 33 ROW: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 34 NEW PRODUCT LAUNCHES: KEY GROWTH STRATEGY ADOPTED BY MAJORITY OF MARKET PLAYERS (2013-2016)
Figure 35 GLOBAL SMALL ANIMAL IMAGING MARKET SHARE, BY KEY PLAYER (2015)
Figure 36 INCREASING NUMBER OF NEW PRODUCTS LAUNCHED IS STIMULATING THE MARKET GROWTH
Figure 37 GEOGRAPHIC REVENUE MIX OF THE TOP 3 MARKET PLAYERS (2015)
Figure 38 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 39 BRUKER CORPORATION: COMPANY SNAPSHOT
Figure 40 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 SMALL ANIMAL IMAGING SYSTEMS MARKET: BOTTOM-UP APPROACH
Figure 4 SMALL ANIMAL IMAGING SYSTEMS MARKET: TOP-DOWN APPROACH
Figure 5 SMALL ANIMAL IMAGING REAGENTS MARKET: TOP-DOWN APPROACH
Figure 6 SMALL ANIMAL IMAGING MARKET: DATA TRIANGULATION
Figure 7 GLOBAL SMALL ANIMAL IMAGING SYSTEMS MARKET, BY MODALITY, 2016 VS. 2021 (USD MILLION)
Figure 8 GLOBAL SMALL ANIMAL IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 9 GLOBAL SMALL ANIMAL IMAGING MARKET, BY REGION, 2016
Figure 10 TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR IMAGING AND INCREASING DEMAND FOR NONINVASIVE TECHNIQUES—KEY MARKET DRIVERS
Figure 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE SMALL ANIMAL IMAGING MARKET IN 2016
Figure 12 OPTICAL IMAGING, NUCLEAR IMAGING, AND MICRO-MRI SYSTEMS TO DOMINATE THE SMALL ANIMAL IMAGING SYSTEMS MARKET TILL 2021
Figure 13 OPTICAL IMAGING, NUCLEAR IMAGING REAGENTS, AND MRI CONTRAST AGENTS TO DOMINATE THE SMALL ANIMAL IMAGING REAGENTS MARKET TILL 2021
Figure 14 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SMALL ANIMAL IMAGING MARKET IN 2016
Figure 15 TECHNOLOGICAL ADVANCEMENTS & EMERGING APPLICATION SEGMENTS TO DRIVE THE GROWTH OF THE SMALL ANIMAL IMAGING MARKET TILL 2021
Figure 16 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES, 2000–2013
Figure 17 MAJORITY OF PRODUCT VALUE OF SMALL ANIMAL IMAGING SYSTEMS IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
Figure 18 MARKET PLAYERS PREFER BOTH DIRECT & INDIRECT DISTRIBUTION STRATEGIES
Figure 19 PORTER’S FIVE FORCES ANALYSIS: SMALL ANIMAL IMAGING MARKET (2015)
Figure 20 OPTICAL IMAGING SYSTEMS TO DOMINATE SMALL ANIMAL IMAGING SYSTEMS MARKET TILL 2021
Figure 21 OPTICAL IMAGING SYSTEMS MARKET TO BE DOMINATED BY BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS IN 2016
Figure 22 MICRO-PET SYSTEMS TO DOMINATE THE NUCLEAR IMAGING SYSTEMS MARKET TILL 2021
Figure 23 MAGNETIC PARTICLE IMAGING VS. OTHER SMALL ANIMAL IMAGING MODALITIES – ADVANTAGES AND KEY APPLICATION AREAS
Figure 24 OPTICAL IMAGING REAGENTS TO DOMINATE THE SMALL ANIMAL IMAGING REAGENTS MARKET TILL 2021
Figure 25 PRECLINICAL OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 26 PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 27 PRECLINICAL MRI CONTRAST AGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 28 PRECLINICAL CT CONTRAST AGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 29 ASIA-PACIFIC TO BE THE FASTEST-GROWING REGION IN GLOBAL SMALL ANIMAL IMAGING MARKET DURING THE FORECAST PERIOD
Figure 30 NORTH AMERICA: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 31 EUROPE: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 32 ASIA-PACIFIC: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 33 ROW: SMALL ANIMAL IMAGING MARKET SNAPSHOT (2016-2021)
Figure 34 NEW PRODUCT LAUNCHES: KEY GROWTH STRATEGY ADOPTED BY MAJORITY OF MARKET PLAYERS (2013-2016)
Figure 35 GLOBAL SMALL ANIMAL IMAGING MARKET SHARE, BY KEY PLAYER (2015)
Figure 36 INCREASING NUMBER OF NEW PRODUCTS LAUNCHED IS STIMULATING THE MARKET GROWTH
Figure 37 GEOGRAPHIC REVENUE MIX OF THE TOP 3 MARKET PLAYERS (2015)
Figure 38 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 39 BRUKER CORPORATION: COMPANY SNAPSHOT
Figure 40 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
